Hongyu Liu

5.6k total citations · 1 hit paper
206 papers, 4.1k citations indexed

About

Hongyu Liu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Hongyu Liu has authored 206 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Molecular Biology, 44 papers in Pulmonary and Respiratory Medicine and 39 papers in Oncology. Recurrent topics in Hongyu Liu's work include Lung Cancer Treatments and Mutations (24 papers), Housing Market and Economics (21 papers) and Lung Cancer Research Studies (12 papers). Hongyu Liu is often cited by papers focused on Lung Cancer Treatments and Mutations (24 papers), Housing Market and Economics (21 papers) and Lung Cancer Research Studies (12 papers). Hongyu Liu collaborates with scholars based in China, United States and Germany. Hongyu Liu's co-authors include Jun Chen, Qinghua Zhou, Yan Xu, Jing Wu, Siqi Zheng, Li Zhang, Matthew E. Kahn, Yongheng Deng, Yuming Fu and Xiangming He and has published in prestigious journals such as Angewandte Chemie International Edition, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Hongyu Liu

188 papers receiving 4.0k citations

Hit Papers

Comparisons between the National Comprehensive Cancer Net... 2010 2026 2015 2020 2010 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hongyu Liu China 34 1.0k 981 880 633 339 206 4.1k
Lanlan Liu China 43 762 0.7× 2.4k 2.5× 570 0.6× 344 0.5× 632 1.9× 280 7.5k
Ming Lü China 35 492 0.5× 662 0.7× 454 0.5× 797 1.3× 231 0.7× 182 4.2k
Lanlan Wang China 35 200 0.2× 838 0.9× 478 0.5× 272 0.4× 455 1.3× 217 4.3k
Patrick A. Singleton United States 48 540 0.5× 2.7k 2.7× 596 0.7× 109 0.2× 447 1.3× 139 6.8k
Kyung Ho Kang South Korea 34 988 1.0× 651 0.7× 317 0.4× 200 0.3× 178 0.5× 211 4.8k
Shuo Hu China 33 592 0.6× 1.4k 1.5× 638 0.7× 398 0.6× 372 1.1× 214 4.4k
Zhenwei Peng China 41 785 0.8× 871 0.9× 933 1.1× 114 0.2× 712 2.1× 190 5.5k
Zhiqiang Wu China 28 333 0.3× 1.2k 1.2× 344 0.4× 77 0.1× 836 2.5× 136 2.7k
Wenjuan Wang China 40 317 0.3× 2.1k 2.2× 439 0.5× 82 0.1× 526 1.6× 408 7.2k
Chen Zhao China 42 259 0.3× 3.9k 4.0× 495 0.6× 180 0.3× 1.4k 4.0× 264 7.1k

Countries citing papers authored by Hongyu Liu

Since Specialization
Citations

This map shows the geographic impact of Hongyu Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongyu Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongyu Liu more than expected).

Fields of papers citing papers by Hongyu Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongyu Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongyu Liu. The network helps show where Hongyu Liu may publish in the future.

Co-authorship network of co-authors of Hongyu Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Hongyu Liu. A scholar is included among the top collaborators of Hongyu Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongyu Liu. Hongyu Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xie, Baocheng, et al.. (2025). Long non-coding RNA MIR4435-2HG modulates pancreatic cancer stem cells and chemosensitivity to gemcitabine by targeting the miR-1252-5p/STAT1. Journal of Translational Medicine. 23(1). 165–165. 5 indexed citations
2.
Diao, Huaian, et al.. (2025). Effective medium theory for embedded obstacles in electromagnetic scattering with applications. Journal of Differential Equations. 437. 113283–113283. 7 indexed citations
3.
Liu, Hongyu, Weiling Guo, Qingxin Cui, et al.. (2024). Effect of TiO2 content on the thermal control properties of Al2O3-xTiO2 composite coatings prepared by supersonic plasma spraying technology. Journal of Materials Research and Technology. 32. 3582–3593. 34 indexed citations
5.
Liu, Yuqing, et al.. (2024). Simultaneous determination of canonical purine metabolism using a newly developed HILIC-MS/MS in cultured cells. Journal of Pharmaceutical and Biomedical Analysis. 252. 116468–116468. 2 indexed citations
6.
Guo, Xinxin, et al.. (2024). 4-Chlorrate Assisted in Situ Passivation of CsPbCl3 Perovskite Quantum Dots with High Water Stability for Light-Emitting Diode. ACS Applied Nano Materials. 7(15). 17561–17568. 3 indexed citations
7.
Zhang, Zihe, Li Y, Ruifeng Shi, et al.. (2024). L3MBTL1, a polycomb protein, promotes Osimertinib acquired resistance through epigenetic regulation of DNA damage response in lung adenocarcinoma. Cell Death and Disease. 15(9). 649–649. 1 indexed citations
8.
Zhang, Hongbing, Xin Li, Jinghao Liu, et al.. (2023). Whole‐exome sequencing in primary pulmonary synovial sarcoma misdiagnosed as mesothelioma: A case report and literature review. Thoracic Cancer. 14(16). 1520–1529. 2 indexed citations
9.
Liu, Minghui, Xiaoyu Niu, Hongyu Liu, & Jun Chen. (2023). Germline EGFR mutations in lung cancer (Review). Oncology Letters. 26(1). 282–282. 10 indexed citations
10.
Liu, Minghui, Hongbing Zhang, Jinghao Liu, et al.. (2023). Apatinib added when NSCLC patients get slow progression with EGFR‐TKI: A prospective, single‐arm study. Cancer Medicine. 12(24). 21735–21741. 3 indexed citations
11.
Zhang, Hongbing, et al.. (2021). Immunotherapy Versus Standard Chemotherapy For Treatment of Extensive-Stage Small-Cell Lung Cancer: A Systematic Review. Immunotherapy. 13(12). 989–1000. 11 indexed citations
12.
Wang, Hongtao, et al.. (2021). Combined Effect of Flaxseed Oil and Vitamin E Supplementation During Bull Semen Cryopreservation on Sperm Characteristics. Biopreservation and Biobanking. 20(6). 520–528. 6 indexed citations
13.
Yang, Fan, Song Xu, Renwang Liu, et al.. (2018). The investigation for potential modifier genes in patients with neurofibromatosis type 1 based on next-generation sequencing. OncoTargets and Therapy. Volume 11. 919–932. 5 indexed citations
14.
Zhang, Dewu, Lili Zhao, Li‐Ning Wang, et al.. (2017). Griseofulvin Derivative and Indole Alkaloids from Penicillium griseofulvum CPCC 400528. Journal of Natural Products. 80(2). 371–376. 33 indexed citations
15.
Wang, Xichen, et al.. (2017). ESMPE: A combined strategy for school tuberculosis prevention and control proposed by Dalian, China. PLoS ONE. 12(10). e0185646–e0185646. 9 indexed citations
17.
Liu, Hongyu, et al.. (2015). Price elasticity of land supply and related impact factors in China. Journal of Tsinghua University(Science and Technology). 55(1). 56–62. 2 indexed citations
18.
Fu, Kai, et al.. (2014). Protective effect of catalpol on lipopolysaccharide-induced acute lung injury in mice. International Immunopharmacology. 23(2). 400–406. 57 indexed citations
20.
Zheng, Siqi & Hongyu Liu. (2004). Interaction among construction investment, other investment and GDP in China. Tsinghua Science & Technology. 9(2). 160–167. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026